Moloney Securities Asset Management, LLC Moderna, Inc. Transaction History
Moloney Securities Asset Management, LLC
- $706 Million
- Q4 2024
A detailed history of Moloney Securities Asset Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Moloney Securities Asset Management, LLC holds 4,854 shares of MRNA stock, worth $191,344. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,854
Previous 10,260
52.69%
Holding current value
$191,344
Previous $685,000
70.66%
% of portfolio
0.03%
Previous 0.1%
Shares
24 transactions
Others Institutions Holding MRNA
# of Institutions
913Shares Held
236MCall Options Held
10.6MPut Options Held
18.7M-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.59 Billion0.05% of portfolio
-
Baillie Gifford & CO38.9MShares$1.53 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.01 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$664 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$285 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $15.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...